The US government next month is to require all non-US nationals to be fully vaccinated against COVID-19 before boarding a flight to the nation, but the Taiwanese vaccine manufactured by Medigen Vaccine Biologics Corp (高端疫苗) is not on Washington’s list of acceptable vaccines.
The new international air travel policy, which is to take effect on Nov. 8, requires all non-citizen, non-immigrant air travelers to be fully vaccinated against COVID-19 before flying to the US.
People are considered fully vaccinated two weeks after they receive their second dose in a two-dose series or two weeks after a single-dose vaccine, the White House said.
Photo: EPA-EFE
Vaccines accepted under the travel policy are those approved or authorized by the US Food and Drug Administration (FDA) and vaccines that have been approved for emergency use by the WHO.
They include the vaccines manufactured by Pfizer-BioNTech, Moderna and AstraZeneca, which have been rolled out in Taiwan, as well as those produced by Johnson and Johnson, and China’s Sinovac and Sinopharm.
People who received two doses of different vaccine brands would also be approved for entry, as long as the two doses were administered at least 17 days apart and the two brands are both included on the FDA or WHO lists.
The vaccine developed by Taiwan’s Medigen is not on either list.
As of Monday, 614,535 people in Taiwan, or about 2.6 percent of the population, had received two doses of the Medigen vaccine, while another 138,119 people had received one dose, government data showed.
The vaccine was approved for emergency use by Taiwan’s FDA in mid-July without having conducted phase 3 clinical trials to determine its efficacy.
Instead, it was approved based on immunobridging, which uses the level of neutralizing antibodies generated by the vaccine in smaller numbers of trial participants to infer its efficacy in combating a virus. That process has not yet been accepted by US health authorities as a basis for approving a vaccine.
The new US travel policy is to replace the one established by the previous administration that banned non-US citizens from entering the nation if they were present in any of 33 “red list” nation in the 14 days prior to traveling.
Some travelers are exempt from the new policy, including children younger than 18 years old and certain COVID-19 vaccine trial participants.
Also exempted are those with medical contraindications to vaccines, those who need to travel for emergency or humanitarian reasons, and those who are traveling on non-tourist visas from nations with less than a 10 percent total vaccination rate.
The updated travel guidelines also include new protocols around testing.
Unvaccinated travelers, including US citizens, would need to provide a negative test within one day of traveling, while those who are vaccinated need to provide a negative test result within three days of traveling.
In response to media queries on whether the new policy would stop President Tsai Ing-wen (蔡英文) and Vice President William Lai (賴清德) from visiting the US as both received the Medigen vaccine, Central Epidemic Command Center spokesman Chuang Jen-hsiang (莊人祥) said in Taipei yesterday that the Ministry of Foreign Affairs is negotiating with Washington in the hope that US visits by Taiwanese officials who have received the Medigen jab would not be affected.
Medigen in a statement yesterday expressed regret for the inconvenience it has caused people as its vaccine has not obtained certification in the US or at the WHO, adding that it is working hard to gain global certifications.
Meanwhile, the WHO yesteday announced the launch of the cosponsored Solidarity Trial Vaccines with the ministries of health of Colombia, Mali and the Philippines.
Medigen is among the candidate vaccines in the trial, the WHO said in a statement.
"The Solidarity Trial Vaccines aims to accelerate the evaluation of multiple promising candidate COVID-19 vaccines, contributing to the creation of a larger portfolio of vaccines needed to protect people from COVID-19 around the world," the statement said.
DAREDEVIL: Honnold said it had always been a dream of his to climb Taipei 101, while a Netflix producer said the skyscraper was ‘a real icon of this country’ US climber Alex Honnold yesterday took on Taiwan’s tallest building, becoming the first person to scale Taipei 101 without a rope, harness or safety net. Hundreds of spectators gathered at the base of the 101-story skyscraper to watch Honnold, 40, embark on his daredevil feat, which was also broadcast live on Netflix. Dressed in a red T-shirt and yellow custom-made climbing shoes, Honnold swiftly moved up the southeast face of the glass and steel building. At one point, he stepped onto a platform midway up to wave down at fans and onlookers who were taking photos. People watching from inside
A Vietnamese migrant worker yesterday won NT$12 million (US$379,627) on a Lunar New Year scratch card in Kaohsiung as part of Taiwan Lottery Co’s (台灣彩券) “NT$12 Million Grand Fortune” (1200萬大吉利) game. The man was the first top-prize winner of the new game launched on Jan. 6 to mark the Lunar New Year. Three Vietnamese migrant workers visited a Taiwan Lottery shop on Xinyue Street in Kaohsiung’s Gangshan District (崗山), a store representative said. The player bought multiple tickets and, after winning nothing, held the final lottery ticket in one hand and rubbed the store’s statue of the Maitreya Buddha’s belly with the other,
‘NATO-PLUS’: ‘Our strategic partners in the Indo-Pacific are facing increasing aggression by the Chinese Communist Party,’ US Representative Rob Wittman said The US House of Representatives on Monday released its version of the Consolidated Appropriations Act, which includes US$1.15 billion to support security cooperation with Taiwan. The omnibus act, covering US$1.2 trillion of spending, allocates US$1 billion for the Taiwan Security Cooperation Initiative, as well as US$150 million for the replacement of defense articles and reimbursement of defense services provided to Taiwan. The fund allocations were based on the US National Defense Authorization Act for fiscal 2026 that was passed by the US Congress last month and authorized up to US$1 billion to the US Defense Security Cooperation Agency in support of the
HIGH-TECH DEAL: Chipmakers that expand in the US would be able to import up to 2.5 times their new capacity with no extra tariffs during an approved construction period Taiwan aims to build a “democratic” high-tech supply chain with the US and form a strategic artificial intelligence (AI) partnership under the new tariffs deal it sealed with Washington last week, Taipei’s top negotiator in the talks said yesterday. US President Donald Trump has pushed Taiwan, a major producer of semiconductors which runs a large trade surplus with the US, to invest more in the US, specifically in chips that power AI. Under the terms of the long-negotiated deal, chipmakers such as Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) that expand US production would incur a lower tariff on semiconductors or related manufacturing
RSS